Contraception: Clinical Trials

6 trials for Contraception, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 terminated. 6 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 36Terminated 6

Follow Contraception: new trials by email Literature Review of Contraception trials Research Report on Contraception

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive
NOMAC-E2 COC - Contraception
Phase 3TerminatedOrganon and Co30552022-02-172025-11-21
A Study of Oral Contraception Under Simulated OTC Conditions
Norgestrel 0.075 mg tablets - Contraception
Phase 3TerminatedHRA Pharma1892018-04-272022-04-04
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring and Levonorgestrel-Ethinyl Estradiol Combined Oral Contraceptive in Adult Women at Risk for Pregnancy (MK-8342B-062)
ENG-E2 125 μg/300 μg vaginal ring, LNG-EE 150 μg/30 μg COC - Contraception
Phase 3TerminatedOrganon and Co20162015-12-012024-05-17
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)
ENG-E2 125 μg/300 μg vaginal ring - Contraception
Phase 3TerminatedOrganon and Co19412015-08-312024-05-17
Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)
NOMAC-E2, NETA-EE, Placebo - Contraception
Phase 3TerminatedOrganon and Co31732012-11-022024-06-20
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
LNG20, Mirena - Contraception
Phase 3TerminatedMedicines36019102009-11-012024-08-14

Interventions

Contraceptive Devices, Female (2)  ·  Estradiol (1)  ·  Ethinyl Estradiol (1)  ·  Levonorgestrel (1)  ·  Norgestrel (1)  ·  etonogestrel (1)  ·  ferrous fumarate (1)  ·  nomegestrol acetate (1)

Sponsors

Organon and Co (4)  ·  HRA Pharma (1)  ·  Medicines360 (1)

Countries

United States (3)  ·  Austria (1)  ·  Costa Rica (1)  ·  Denmark (1)  ·  Finland (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Peru (1)  ·  Poland (1)  ·  South Africa (1)  ·  Sweden (1)

Top investigators

Andrea Olariu, MD, PhD (1)  ·  Russell Bradford, MD, MSPH (1)

Results publications

PMID 25934164, PMID 27125892, PMID 29038072, PMID 29560743, PMID 30531565, PMID 31069056, PMID 31866516, PMID 37023451, PMID 38969201

NIH funding

2014 (1)